Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 意见
• 08/09/23
0
0
嵌入
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论